Efficacy and safety of the anti-TNF biologic agents

ISSN： 1439-7595

Source： Modern Rheumatology, Vol.14, Iss.2, 2004-06, pp. : 101-112

Disclaimer: Any content in publications that violate the sovereignty, the constitution or regulations of the PRC is not accepted or approved by CNPIEC.

Previous Menu Next

Related content

Onset of psoriasis in patients with inflammatory bowel disease treated with anti-TNF agents

By Guerra Iván Gisbert Javier P

Expert Review of Gastroenterology and Hepatology, Vol. 7, Iss. 1, 2013-01 ,pp. : 41-48

Informa Healthcare

Access to resources Recommend Favorite

Complications of anti-TNF therapies

By Ding Tina Deighton Chris

Future Rheumatology, Vol. 2, Iss. 6, 2007-12 ,pp. : 587-597

Future Medicine

Access to resources Recommend Favorite

Disease Duration Did Not Influence the Rates of Loss of Efficacy of the Anti-TNF Therapy in Latin American Crohn's Disease Patients

Digestion, Vol. 91, Iss. 2, 2015-02 ,pp. : 158-163

Karger

Access to resources Recommend Favorite

Tuberculosis after anti-TNF therapy

By Pamuk Ömer Dönmez Salim

Clinical Rheumatology, Vol. 28, Iss. 6, 2009-06 ,pp. : 747-747

Springer Publishing Company

Access to resources Recommend Favorite

Mucosal Healing with Anti-TNF Antibodies

Digestion, Vol. 86, Iss. 1, 2012-10 ,pp. : 16-22

Karger

Access to resources Recommend Favorite